Disease Markers

Table of Contents

  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9845626
  • - Retraction

Retracted: The Efficacy of Rosuvastatin, Amlodipine, and Aspirin in the Treatment of Hypertension with Coronary Heart Disease and Its Effect on Platelet Aggregation

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9838245
  • - Retraction

Retracted: Correlation between Glycated Haemoglobin Level, Cardiac Function, and Prognosis in Patients with Diabetes Mellitus Combined with Myocardial Infarction

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9836714
  • - Retraction

Retracted: Registered Trials of Artificial Intelligence Conducted on Chronic Liver Disease: A Cross-Sectional Study on ClinicalTrials.Gov

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9836565
  • - Retraction

Retracted: Application of Preoperative Adductor Canal Block Coupled with General Anaesthesia in Elderly Patients Undergoing Total Knee Arthroplasty

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9836340
  • - Retraction

Retracted: BERT-Based Clinical Name Entity Reorganization Model for Health Diagnosis

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9832937
  • - Retraction

Retracted: Endovascular Repair of the Thoracic Aorta Combined with Drug Therapy in Acute Uncomplicated Type B Aortic Dissection

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9832431
  • - Retraction

Retracted: Exploration of RCBF and Metabolic Changes in the Brain Functional Areas of Patients with Hypothyroidism by ASL and MRS Techniques

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9830503
  • - Retraction

Retracted: Antimicrobial Step-Down Therapy versus Conventional Antimicrobial Therapy in the Treatment of Patients with Sepsis

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9826032
  • - Retraction

Retracted: Clinical Application of Anlotinib Combined with Docetaxel: Safe and Effective Treatment for Lung Carcinoma

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9823853
  • - Retraction

Retracted: Correlation of Clinicopathological Factors with Brain Tumor-Related Epilepsy in Glioma

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9823410
  • - Retraction

Retracted: To Explore and Analyze the Safety and Clinical Efficacy of Periocline-Assisted Periodontal Basic Therapy on Chronic Periodontitis

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9820901
  • - Retraction

Retracted: Exogenous Hydrogen Sulfide Mitigates Oxidative Stress and Mitochondrial Damages Induced by Polystyrene Microplastics in Osteoblastic Cells of Mice

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9818951
  • - Retraction

Retracted: The Clinical Efficacy and Safety of Extracorporeal Shock Wave Lithotripsy in the Treatment of Patients with Urinary Calculi

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9818597
  • - Retraction

Retracted: Research on Polycaprolactone-Gelatin Composite Scaffolds Carrying Nerve Growth Factor for the Repair of Spinal Cord Injury

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9816872
  • - Retraction

Retracted: A Meta-analysis: Cost Comparison of Flow Diversion and Coil Embolization for Intracranial Aneurysm

Disease Markers
Disease Markers
 Journal metrics
See full report
Acceptance rate6%
Submission to final decision131 days
Acceptance to publication42 days
CiteScore3.700
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.